title: Pharmacokinetic (PK) Differences Between Subcutaneous and Intramuscular Administration of Lanreotide: Results From a Phase I Study.
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D064368:Healthy Volunteers; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D010456:Peptides, Cyclic / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D016032:Randomized Controlled Trials as Topic; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin